Yuyu Pharma Signs Contract for Baseball Field Ad Campaign

SEOUL, South Korea, May 28, 2020 /PRNewswire/ -- Yuyu Pharma [http://www.yuyu.co.kr/en] (CEO Robert Wonsang Yu, KRX 000220), a Korean pharmaceutical company, recently signed an advertising contract with the Korea Economic Daily, which holds the advertising business rights of the Jamsil Baseball Stadium in Seoul. As part of the new ad campaign, Yuyu Pharma's logo will be painted along the first base line at the stadium and will be visible during televised games.

https://mma.prnewswire.com/media/1173251/YuyuPharma.jpg [https://mma.prnewswire.com/media/1173251/YuyuPharma.jpg]

Jamsil Baseball Stadium, founded in 1980, is the home of Korean professional baseball as well as the home stadium of the Doosan Bears and LG Twins, two popular Korea Baseball Organization (KBO) League teams.

The Yuyu Pharma ad campaign will highlight the company throughout the world, as KBO League games are being broadcast overseas to 130 countries, including in the Americas, Asia, Europe, the Middle East, and Africa. The first base line position of the ad will provide the company with ample exposure to attract potential customers, talent, and further partnerships.

Robert Yu, CEO of Yuyu Pharma, stated: "Through baseball advertising, we expect that the new campaign will lead to a ripple effect, creating increased sales and securing outstanding talent based on strengthened corporate recognition, not only in Korea but also abroad."

About Yuyu Pharma

Yuyu Pharma (KRX: 000220) is a pharmaceutical company founded in 1941. The company manufactures, distributes, and does marketing for pharmaceutical products, medical devices, and medical foods in South Korea and Southeast Asia. Currently, Yuyu Pharma is focusing on developing new drugs for treating enlarged prostates and dry eye syndrome.

For Media Enquiries:

Sean Yoon hjyoon@yuyu.co.kr [mailto:hjyoon@yuyu.co.kr]

Photo - https://mma.prnewswire.com/media/1173251/YuyuPharma.jpg [https://mma.prnewswire.com/media/1173251/YuyuPharma.jpg]

CONTACT: +82-2-6972-9127

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Verstuur nu éénmalig een persbericht

Verstuur persberichten en beeldmateriaal naar redacties in binnen- en buitenland. Via het ANP-net, het internationale medianetwerk van PR Newswire of met een perslijst op maat.

Direct persbericht versturen
070 - 41 41 234